Role of Regulatory Non-coding RNAs in Traumatic Brain Injury
Overview
Authors
Affiliations
Traumatic brain injury (TBI) is a potentially fatal health event that cannot be predicted in advance. After TBI occurs, it can have enduring consequences within both familial and social spheres. Yet, despite extensive efforts to improve medical interventions and tailor healthcare services, TBI still remains a major contributor to global disability and mortality rates. The prompt and accurate diagnosis of TBI in clinical contexts, coupled with the implementation of effective therapeutic strategies, remains an arduous challenge. However, a deeper understanding of changes in gene expression and the underlying molecular regulatory processes may alleviate this pressing issue. In recent years, the study of regulatory non-coding RNAs (ncRNAs), a diverse class of RNA molecules with regulatory functions, has been a potential game changer in TBI research. Notably, the identification of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and other ncRNAs has revealed their potential as novel diagnostic biomarkers and therapeutic targets for TBI, owing to their ability to regulate the expression of numerous genes. In this review, we seek to provide a comprehensive overview of the functions of regulatory ncRNAs in TBI. We also summarize regulatory ncRNAs used for treatment in animal models, as well as miRNAs, lncRNAs, and circRNAs that served as biomarkers for TBI diagnosis and prognosis. Finally, we discuss future challenges and prospects in diagnosing and treating TBI patients in the clinical settings.
Vakilzadehian N, Moradi Y, Allela O, Al-Hussainy A, Ali Al-Nuaimi A, Kadhim A Al-Hussein R Int J Mol Cell Med. 2025; 13(4):417-435.
PMID: 39895920 PMC: 11786126. DOI: 10.22088/IJMCM.BUMS.13.4.417.
Research progress on digestive disorders following traumatic brain injury.
Lin Y, Hou C, Wang C, Chen R, Zhu Y, Zhou Q Front Immunol. 2025; 15:1524495.
PMID: 39759513 PMC: 11695231. DOI: 10.3389/fimmu.2024.1524495.
Sex and Age-Dependent Effects of miR-15a/16-1 Antagomir on Ischemic Stroke Outcomes.
Huang X, Li S, Qiu N, Ni A, Xiong T, Xue J Int J Mol Sci. 2024; 25(21).
PMID: 39519316 PMC: 11546232. DOI: 10.3390/ijms252111765.
Sha P, Gao X, Yu R, Li Y, Zhang Y, Zhu Z Front Neurol. 2024; 15:1449417.
PMID: 39228512 PMC: 11368751. DOI: 10.3389/fneur.2024.1449417.
Rai V, Mendoza-Mari Y, Radwan M, Brazdzionis J, Connett D, Miulli D J Bioinform Syst Biol. 2024; 7(1):81-91.
PMID: 38818113 PMC: 11138201. DOI: 10.26502/jbsb.5107080.